Pulmonary vascular effects of inhaled nitric oxide and oxygen tension in bronchopulmonary dysplasia (Q43940289)

28 November 2017

Pulmonary vascular effects of inhaled nitric oxide and oxygen tension in bronchopulmonary dysplasia (English)

1 reference

bronchopulmonary dysplasia

28 November 2017

1 reference

Peter M Mourani

1

1 reference

28 November 2017

D Dunbar Ivy

series ordinal

2

1 reference

28 November 2017

Dexiang Gao

series ordinal

3

1 reference

28 November 2017

Steven H Abman

series ordinal

4

1 reference

28 November 2017

language of work or name

English

0 references

publication date

7 June 2004

1 reference

American Journal of Respiratory and Critical Care Medicine

28 November 2017

1 reference

28 November 2017

170

1 reference

28 November 2017

1006-1013

1 reference

28 November 2017

9

1 reference

Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia

28 November 2017

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200310-1483OC

Bronchopulmonary dysplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200310-1483OC

Pulmonary function in infancy and in childhood following mechanical ventilation in the neonatal period

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200310-1483OC

Long-term pulmonary functional outcome of bronchopulmonary dysplasia and premature birth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200310-1483OC

Pulmonary vascular changes in bronchopulmonary dysplasia: a clinicopathologic correlation in short- and long-term survivors

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200310-1483OC

Changes in pulmonary circulation in severe bronchopulmonary dysplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200310-1483OC

Pathology of new bronchopulmonary dysplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200310-1483OC

Acute hemodynamic effects of nifedipine in infants with bronchopulmonary dysplasia and pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200310-1483OC

Pharmacokinetics and pharmacodynamics of nifedipine in children with bronchopulmonary dysplasia and pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200310-1483OC

Long-term follow-up of bronchopulmonary dysplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200310-1483OC

Monitoring cardiovascular function in infants with chronic lung disease of prematurity

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200310-1483OC

Changes in oxygenation with inhaled nitric oxide in severe bronchopulmonary dysplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200310-1483OC

Inhaled nitric oxide in premature infants with the respiratory distress syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200310-1483OC

Inhaled nitric oxide as a screening agent for safely identifying responders to oral calcium-channel blockers in primary pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200310-1483OC

Inhaled nitric oxide in primary pulmonary hypertension: a safe and effective agent for predicting response to nifedipine

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200310-1483OC

Primary pulmonary hypertension: Current therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200310-1483OC

Pulsed delivery of inhaled nitric oxide to patients with primary pulmonary hypertension: an ambulatory delivery system and initial clinical tests

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200310-1483OC

Increased lung vasoreactivity in children from Leadville, Colorado, after recovery from high-altitude pulmonary edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200310-1483OC

Combined effects of nitric oxide and oxygen during acute pulmonary vasodilator testing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200310-1483OC

Effects of dipyridamole and inhaled nitric oxide in pediatric patients with pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200310-1483OC

10.1164/RCCM.200310-1483OC

21 January 2018

Identifiers

DOI

1 reference

28 November 2017

1 reference